MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells that are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice

Journal of Immunology

Volumn 172, Issue 2, 2004, Pages 871-879

  Serreze, David V ^a   Holl, T Matthew ^a   Marron, Michele P ^a   Graser, Robert T ^a   Johnson, Ellis A ^a   Choisy Rossi, Caroline ^a   Slattery, Robyn M ^b   Lieberman, Scott M ^c   DiLorenzo, Teresa P ^c  

^a JACKSON LABORATORY   (United States)

^b Biology and Environment   (Australia)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

EID: 1642577122     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.2.871     Document Type: Article

References (50)

1. Todd, J. A., and L. S. Wicker. 2001. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15:387.
2. Serreze, D. V., and E. H. Leiter. 2001. Genes and pathways underlying autoimmune diabetes in NOD mice. In Molecular Pathology of Insulin Dependent Diabetes Mellitus. M. G. von Herrath, ed. Karger Press, New York, p. 31.
3. Nepom, G. T., and W. W. Kwok. 1998. Molecular basis for HLA-DQ associations with IDDM. Diabetes 47:1177.
4. nod to the development of insulitis in non-obese diabetic mice. Nature 345:722.
5. Lund, T., L. O'Reilly, P. Hutchings, O. Kanagawa, E. Simpson, R. Gravely, P. Chandler, J. Dyson, J. K. Picard, A. Edwards, D. Kioussis, and A. Cooke. 1990. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 345:727.
6. k transgenic mice. Nature 345:724.
7. d transgene prevents diabetes in nonobese diabetic mice by inducing regulatory T cells. Proc. Natl. Acad. Sci. USA 90:9566.
8. b transgene. Diabetes 47:1570.
9. Hanson, M. S., M. Cetkovic-Cvrlje, V. K. Ramiya, M. A. Atkinson, N. K. MacLaren, B. Singh, J. F. Elliott, D. V. Serreze, and E. H. Leiter. 1996. Quantitative thresholds of MHC class II I-E expressed on hematopoietically derived APC in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J. Immunol. 157:1279.
10. Schmidt, D., J. Verdaguer, N. Averill, and P. Santamaria. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059.
11. + thymocytes by protective MHC class II molecules. J. Immunol. 162:4627.
12. Thiessen, S. J., P. Serra, A. Amrani, J. Verdaguer, and P. Santamaria. 2002. T cell tolerance by dendritic cells and macrophages as a mechanism for the major histocompatibility complex-linked resistance to autoimmune diabetes. Diabetes 51:325.
13. null mice are diabetes and insulin resistant. Diabetes 43:505.
14. 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 43:500.
15. Serreze, D. V., H. D. Chapman, D. S. Varnum, I. Gerling, E. H. Leiter, and L. D. Shultz. 1997. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. J. Immunol. 158:3978.
16. DiLorenzo, T. P., R. T. Graser, T. Ono, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 1998. MHC class I-restricted T cells are required for all but the end stages of diabetes development in NOD mice and utilize a prevalent T cell receptor α chain gene rearrangement. Proc. Natl. Acad. Sci. USA 95:12538.
17. Fennessy, M., K. Metcalfe, G. A. Hitman, M. Niven, P. A. Biro, J. Tuomilehto, and E. Tuomilehto-Wolf. 1994. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Diabetologia 37:937.
18. Demaine, A. G., M. L. Hibberd, D. Mangles, and B. A. Millward. 1995. A new marker in the HLA class I region is associated with the age at onset of IDDM. Diabetologia 38:622.
19. Honeyman, M. C., L. C. Harrison, B. Drummond, P. G. Colman, and B. D. Tait. 1995. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1:576.
20. Nejentsev, S., H. Reijonen, B. Adojaan, L. Kovalchuk, A. Sochnevs, E. I. Schwartz, H. K. Akerblom, and J. Honen. 1997. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 46:1888.
21. Nejentsev, S., Z. Gombos, A.-P. Laine, R. Veijola, M. Knip, O. Simell, O. Vaarala, H. K. Akerblom, and J. Honen. 2000. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 49:2217.
22. Undlien, D. E., B. A. Lie, and E. Thorsby. 2001. HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved?. Trends Genet. 17:93.
23. Robles, D. T., G. S. Eisenbarth, T. Wang, H. A. Erlich, T. L. Bugawan, S. R. Babu, K. Barriga, J. Norris, M. Hoffman, G. Klingensmith, L. Yu, and M. Rewers. 2002. Identification of children with early onset and high incidence of anti-islet autoantibodies. Clin. Immunol. 102:217.
24. Marron, M. P., R. T. Graser, H. D. Chapman, and D. V. Serreze. 2002. Functional evidence for the mediation of diabetogenic T cell responses by human HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc. Natl. Acad. Sci. USA 99:13753.
25. Graser, R. T., T. P. DiLorenzo, F. Wang, G. J. Christianson, H. D. Chapman, D. C. Roopenian, S. G. Nathenson, and D. V. Serreze. 2000. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J. Immunol. 164:3913.
26. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Leiter. 1992. The nonobese diabetic scid mouse: Model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89:3290.
27. Prochazka, M., D. V. Serreze, S. M. Worthen, and E. H. Leiter. 1989. Genetic control of diabetogenesis in NOD/Lt mice: development and analysis of congenic stocks. Diabetes 38:1446.
28. + cytotoxic T lymphocyte responses in autoimmune diabetes prone NOD mice. Diabetes 45:902.
29. Wicker, L. S., M. C. Appel, F. Dotta, A. Pressey, B. J. Miller, N. H. DeLarto, P. A. Fischer, R. C. Boltz, and L. B. Peterson. 1992. Autoimmune syndromes in major histocompatability complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J. Exp. Med. 176:67.
30. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, and D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.
31. + T cell population comprises multiple antigenic specificities. Clin. Immunol. 105:332.
32. Weiss, E., L. Golden, R. Zakut, A. Mellor, K. Fahrner, S. Kvist, and R. A. Flavell. 1983. The DNA sequence of the H-2Kb gene: Evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibility antigens. EMBO J. 2:453.
33. 2-microglobulin as a diabetes susceptibility gene in NOD mice. Proc. Natl. Acad. Sci. USA 98:11533.
34. Serreze, D. V., and E. H. Leiter. 1991. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hematopoietic origin, but not on thymic epithelium. J. Immunol. 147:1222.
35. Serreze, D. V., H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch. 2001. Th1 to Th2 cytokine shifts in NOD mice: Sometimes an outcome, rather than the cause of diabetes resistance elicited by immunostimulation. J. Immunol. 166:1352.
36. Palmer, E. 2003. Negative selection-clearing out the bad apples from the T cell repertoire. Nat. Rev. Immunol. 3:383.
37. Sebzda, E., S. Mariathasan, T. Ohteki, R. Jones, M. F. Bachmann, and P. S. Ohashi. 1999. Selection of the T cell repertoire. Annu. Rev. Immunol. 17:829.
38. Graser, R. T., C. E. Mathews, E. H. Leiter, and D. V. Serreze. 1999. MHC characterization of ALR and ALS mice: Respective similarities to the NOD and NON strains. Immunogenetics 49:722.
39. Heath, W. R., and J. F. A. P. Miller. 1993. Expression of two α chains on the surface of T cells in T cell receptor transgenic mice. J. Exp. Med. 178:1807.
40. Hardardottir, F., J. L. Baron, and C. A. Janeway. 1995. T cells with two functional antigen-specific receptors. Proc. Natl. Acad. Sci. USA 92:354.
41. + T cells both trigger CD4/CD8-shared and CD4-unique functions. J. Immunol. 158:4533.
42. Johnson, E. A., P. Silveira, H. D. Chapman, E. H. Leiter, and D. V. Serreze. 2001. Inhibition of autoimmune diabetes in nonobese diabetic mice by transgenic restoration of H2-E MHC class II expression: Additive, but unequal, involvement of multiple APC subtypes. J. Immunol. 167:2404.
43. Miller, J. F. A. P., and A. Basten. 1996. Mechanisms of tolerance to self. Curr. Opin. Immunol. 8:815.
44. Shimizu, T. and S. Takeda. 1997. CD8 T cells from major histocompatibility complex class II-deficient mice respond vigorously to class II molecules in a primary mixed lymphocyte reaction. Eur. J. Immunol. 27:500.
45. Dautigny, N., A. LeCampion, and B. Lucas. 1999. Timing and casting for actors of thymic negative selection. J. Immunol. 162:1294.
46. Arsov, I. and S. Vukmanovic. 1999. Dual MHC class I and class II restriction of a single T cell receptor: Distinct modes of tolerance induction by two classes of autoantigens. J. Immunol. 162:2008.
47. Amrani, A., P. Serra, J. Yamanouchi, J. D. Trudeau, R. Tan, J. F. Elliott, and P. Santamaria. 2001. Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation. J. Immunol. 167:655.
48. Amrani, A., J. Verdaguer, P. Serra, S. Tafuro, R. Tan, and P. Santamaria. 2000. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406:739.
49. + T lymphocytes. Proc. Natl. Acad. Sci. USA 99:15566.
50. Beilhack, G. F., Y. C. Scheffold, I. L. Weismann, C. Taylor, L. Jerabeck, M. J. Burge, M. A. Masek, and J. A. Shizuru. 2003. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 52:59.